Season 2 is Coming Soon

Clinical Trialblazers will be back soon! Season 2 will bring together a dynamic mix of biotech innovators, executives, and industry leaders to reveal the strategy and teamwork fueling the next wave of clinical breakthroughs. Across 10 new episodes, host Alberto Grignolo will explore high-stakes decisions, unexpected hurdles, and the defining moments that shape both careers and clinical milestones. Season 2 of Clinical Trialblazers is streaming soon wherever you listen to podcasts.

An episode of the Clinical Trialblazers podcast, hosted by Parexel, titled "Season 2 is Coming Soon" was published on February 17, 2026 and runs 1 minutes.

February 17, 2026 ·1m · Clinical Trialblazers

0:00 / 0:00

Summary

Clinical Trialblazers will be back soon! Season 2 will bring together a dynamic mix of biotech innovators, executives, and industry leaders to reveal the strategy and teamwork fueling the next wave of clinical breakthroughs. Across 10 new episodes, host Alberto Grignolo will explore high-stakes decisions, unexpected hurdles, and the defining moments that shape both careers and clinical milestones. Season 2 of Clinical Trialblazers is streaming soon wherever you listen to podcasts.

Episode Description

Clinical Trialblazers will be back soon! Season 2 will bring together a dynamic mix of biotech innovators, executives, and industry leaders to reveal the strategy and teamwork fueling the next wave of clinical breakthroughs. Across 10 new episodes, host Alberto Grignolo will explore high-stakes decisions, unexpected hurdles, and the defining moments that shape both careers and clinical milestones. Season 2 of Clinical Trialblazers is streaming soon wherever you listen to podcasts.

Share this episode

Similar Episodes

Prof. Chantal Mathieu, MD, PhD - Betting on Basal Insulin: Improving the Odds for People With Type 2 Diabetes

Apr 3, 2026 ·67m

Tanios Bekaii-Saab, MD, FACP, FASCO - Raising the Game in Biliary Cancer: Adapting Rapidly Emerging Evidence and Achieving Optimal Disease Control With FGFR-Targeted Platforms

Apr 3, 2026 ·34m

Joyce O'Shaughnessy, MD - Raising the Bar for Survival in High-Risk HR+, HER2- EBC: A Practical Framework for the Adjuvant Setting; Real-World Strategies to Improve Risk Assessment, Candidate Identification, Differentiated CDK4/6i + ET Selection, and Optimal Treatment Delivery

Apr 3, 2026 ·58m

Yelena Y. Janjigian, MD*, Marion Liu, MD - Unifying Surgical-Oncology Expertise in Resectable Gastric/GEJ Malignancies: Leveraging the Evidence on Perioperative Immunotherapy Platforms to Deliver Personalized Care

Apr 3, 2026 ·64m

Laura S. Dominici, MD, FACS - Lighting the Path in Early Breast Cancer Care: Uniting Evidence, Expertise, and Multidisciplinary Action

Apr 3, 2026 ·80m

Hope S. Rugo, MD, FASCO - From Evidence to Impact: Harnessing PI3K/AKT/mTOR Pathway Inhibitors to Improve Outcomes in HR+, HER2- MBC; Shedding Light on Mechanisms, Clinical Evidence, and Adverse Event Management

Apr 3, 2026 ·43m

Similar Podcasts

Clinical relevance of awakening part 2 Lisa Dale Miller, LMFT David Vago, PhD and Lisa Dale Miller, LMFT, LPCC, SEP tackle the traditional Buddhist concept of "enlightenment" from their modern clinical points of view in a stimulating and fun discussion. Part 2 focuses on S-ART, David's neurobiological framework for describing the positive effects of meditation on self-awareness, self-regulation, and self-transcendence; Theravada, Mahāyāna and Vajrayāna notions of awakening and not-self; secular mental training; different interventions for different psyches; selflessness/emptiness in psychotherapy; translating the dharma into neuropsychological terms, vedanā (craving and aversion); decentering, embodied cognition; aggregates and seeds of habit mind; other-centeredness and not-self; non-referential compassion; empathy fatigue; refuting self-compassion; clinical Tonglen practice; neurobiological evidence for not-self states; developmental model of awakening; dynamic responsiveness; neurotherapeutics.David Vago, PhD is an associate psychologist in t Clinical relevance of awakening Lisa Dale Miller, LMFT David Vago, PhD and Lisa Dale Miller, LMFT, LPCC, SEP tackle the traditional Buddhist concept of "enlightenment" from their modern clinical points of view in a stimulating and fun discussion. Part 2 focuses on S-ART, David's neurobiological framework for describing the positive effects of meditation on self-awareness, self-regulation, and self-transcendence; Theravada, Mahāyāna and Vajrayāna notions of awakening and not-self; secular mental training; different interventions for different psyches; selflessness/emptiness in psychotherapy; translating the dharma into neuropsychological terms, vedanā (craving and aversion); decentering, embodied cognition; aggregates and seeds of habit mind; other-centeredness and not-self; non-referential compassion; empathy fatigue; refuting self-compassion; clinical Tonglen practice; neurobiological evidence for not-self states; developmental model of awakening; dynamic responsiveness; neurotherapeutics.David Vago, PhD is an associate psychologist in t Clinical Appraisal Ian A. Lane Evaluating the science and theory of nursing through a rigorous methodological lens Clinical Diabetes Management In this series for medical professionals, specialists from pharmacy, podiatry, optometry, and dental professions discuss preventing diabetes complications and working as part of the diabetes care team.

URL copied to clipboard!